Bioinformatic analysis using high-throughput RNA-sequencing data from TCGA and METABRIC demonstrated that the reduced expression of TLR3 in breast cancer was associated with survival time, and poor prognosis. This evidence concerns the gene TLR3 and breast carcinoma.